Latest Company Research from Morningstar

GlaxoSmithKline, SABMiller, RBS and various other companies have all been under our analysts’ microscopes this week

Alanna Petroff 20 April, 2012 | 6:37PM
Facebook Twitter LinkedIn

Morningstar's global team of analysts have been busy this week updating research on a range of UK and European companies. Below you can find key information about the new research on these large-cap companies:

Banco Santander (BNC): Morningstar analyst Maclovio Pina has slashed his fair value estimate for the Spanish bank, explaining that the cut was “mainly [due] to a rise in our cost of equity estimate and higher credit loss estimates ... In our view, Santander still has to face plenty of loan losses, with net charge-offs of about 1.8% of loans in 2012 and 2013 (versus 1.6% in 2011).” Furthermore, he expects the bank’s expansion will be muted in the next couple of years.
View Morningstar’s latest research on Banco Santander

BHP Billiton (BLT): The latest research report discusses BHP’s results from its most recent quarter. Morningstar analyst Mark Taylor says he’s heartened by the latest BHP numbers.
View Morningstar’s latest research on BHP Billiton

GlaxoSmithKline (GSK): Morningstar analyst Damien Conover discusses GSK’s unsolicited bid for Human Genome Sciences (HGSI), saying they'll likely come back with a sweetened offer.
View Morningstar’s latest research on GlaxoSmithKline

International Power (IPR): This new research discusses International Power’s latest quarterly figures and reviews GDF Suez’s (GSZ) takeover bid for the company, which is expected to be approved by shareholders in mid-May.
View Morningstar’s latest research on International Power

Royal Bank of Scotland Group (RBS): Morningstar analyst Erin Davis says that while RBS hasn’t turned a full-year profit since 2007, a profit can be expected for this year, though it will be modest. Her current fair value estimate indicates the company is being undervalued by the market.
View Morningstar’s latest research on Royal Bank of Scotland Group

Rio Tinto (RIO): Morningstar analyst Mark Taylor examines Rio Tinto’s latest quarterly numbers, reiterating that he believes the company is being undervalued by the market.
View Morningstar’s latest research on Rio Tinto

SABMiller (SAB): After looking through the company’s full-year 2012 trading update, Morningstar analyst Thomas Mullarkey writes that “the company continues to post healthy volume growth in the emerging markets of Latin America and Africa, which offset volume declines in Europe and North America and slowing demand growth in Asia.” He believes the company is currently being overvalued by the market.
View Morningstar’s latest research on SABMiller

Tesco (TSCO): Morningstar analyst Michael Keara expresses some concerns about the company’s profit margins after the grocery giant announced plans to invest GBP 1 billion into its UK stores.
View Morningstar’s latest research on Tesco

3 Ways to Access Morningstar Research
Security-Specific Searches
: The quickest way to access our analysts' view on a particular stock or fund is to look up that security using the Search box at the top of every Morningstar.co.uk webpage (top tip: as you type the security's name, wait for the dropbox to appear and select your security from the list). If our analysts cover the stock or fund you're searching for, you'll see either a 'Stock Analysis' tab or an 'Analyst Research' tab available to Premium users.

Latest Research: Premium subscribers can see at a glance the latest research published by Morningstar analysts in our Latest Morningstar Research section, housed on the right-hand side of the front page. Click the relevant tab ('All', 'Funds', 'Equities', 'ETFs' or 'Investment Trusts') to see the most up-to-date research reports issued by those analyst teams.

Top-Rated Stocks and Funds: If you're not sure what you're looking for or you're in need of some investment inspiration, try using our Screener tools to search for securities that have earned Morningstar analysts' top ratings. Morningstar Quickrank tools are another good way to rank securities--equities or any type of fund--according to their Morningstar rating. All these tools are available on the Tools page.

Ensure you're signed in to your Premium service to read Morningstar research as our analysts' opinions are available only to Premium subscribers.

Reminder About Morningstar Ratings
Remember, Morningstar publishes different types of rating for stocks and funds.

For stocks, we publish a Star Rating that measures the difference between our independent analysts' fair value estimate and the stock's latest price. It's essentially a measure of whether we think a stock is currently under-, over- or fairly valued. Star Ratings for stocks are reassessed automatically each day according to the latest closing price.

For funds, we publish a different type of Star Rating. This is used across the funds universe--unit trusts and OEICs, investment trusts and ETFs--to measure performance against peers. It is a backward-looking, risk-adjusted assessment of the last three years of returns.

The second type of rating for funds is our Analyst Rating, which tells you what our team of independent analysts think of a fund's whole package--managers, fees, company, performance and strategy. This is a forward-looking, qualitative assessment.

To read more about our research, take a look at our methodology page.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Alanna Petroff

Alanna Petroff  is a financial journalist with Morningstar UK.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures